Investors evaluating inverse leveraged strategies often compare products that deliver amplified downside exposure across different market segments. HIBS and TZA both seek daily investment results equal to 300% of the inverse performance of their respective benchmarks before fees. They do not compete head-to-head but instead offer alternative inverse exposure: one targeting high-beta constituents of the S&P 500 and the other focusing on the Russell 2000 small-cap universe. This distinction makes the pair relevant for portfolio hedging, sector rotation tactics, or short-term bearish positioning within large-cap volatility or small-cap equities.
HIBS seeks daily results, before fees and expenses, of 300% of the inverse of the S&P 500 High Beta Index. The index selects the 100 securities from the S&P 500 with the highest beta over the prior 12 months and weights them accordingly. The ETF is passively managed and non-diversified, typically holding a small number of holdings supplemented by derivatives to achieve its target exposure. Its gross expense ratio is 1.11% with a net expense ratio of 1.06%. Key structural features include daily rebalancing through swaps, futures, and other instruments to maintain the -3x daily objective. The fund is designed for single-day results and carries the compounding effects inherent to leveraged products.
TZA seeks daily results, before fees and expenses, of 300% of the inverse of the Russell 2000 Index. The benchmark measures the performance of roughly 2,000 small-capitalization companies within the Russell 3000 Index, weighted by market capitalization. Like HIBS, TZA is passively managed and non-diversified, relying on swaps, futures, and short positions to deliver its -3x daily target. Its expense ratio is 0.99%. The fund resets exposure daily and is structured for short-term trading horizons rather than longer-term holding periods.
Both ETFs operate within the leveraged and inverse equity category, responding to broader equity market volatility, interest rate expectations, and sector rotation between large-cap and small-cap segments. High-beta stocks within the S&P 500 tend to exhibit amplified sensitivity to macroeconomic shifts, while small-cap companies in the Russell 2000 often reflect domestic economic conditions and growth prospects. Regulatory oversight of leveraged products emphasizes daily reset mechanics and risk disclosures. Capital flows into inverse strategies typically increase during periods of elevated market uncertainty or anticipated equity weakness.
In recent market cycles, HIBS has provided amplified inverse exposure to volatile large-cap names, with performance tied to movements in high-beta sectors such as technology and consumer discretionary. TZA has delivered inverse results linked to small-cap earnings trends, interest rate sensitivity, and domestic economic indicators. Relative positioning differs due to index composition: HIBS captures leverage on market leaders with high sensitivity, while TZA reflects broader small-cap dynamics. Both exhibit significant volatility and path dependency from daily compounding, leading to potential divergence from benchmark multiples over multi-day periods.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.
Based on structural characteristics, TZA may receive a slight probabilistic edge in current conditions due to its marginally lower expense ratio, broader small-cap diversification within the Russell 2000, and established liquidity profile. However, HIBS offers targeted inverse exposure to high-beta large caps that could align with specific volatility-driven strategies. Selection ultimately depends on an investor’s desired segment exposure, risk tolerance, and time horizon.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HIBS saw its Momentum Indicator move above the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 88 similar instances where the indicator turned positive. In 81 of the 88 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Moving Average Convergence Divergence (MACD) for HIBS just turned positive on October 12, 2026. Looking at past instances where HIBS's MACD turned positive, the stock continued to rise in 48 of 52 cases over the following month. The odds of a continued upward trend are 90%.
HIBS moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +13.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIBS advanced for three days, in 238 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
HIBS broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HIBS entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Moving Average Convergence Divergence (MACD) for TZA turned positive on October 13, 2026. Looking at past instances where TZA's MACD turned positive, the stock continued to rise in 42 of 43 cases over the following month. The odds of a continued upward trend are 90%.
Following a +7.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where TZA advanced for three days, in 249 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 162 of 180 cases where TZA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The 10-day RSI Indicator for TZA moved out of overbought territory on October 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 26 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TZA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
TZA broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| HIBS | TZA | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 90% | N/A |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 3 days ago 87% | 3 days ago 90% |
| Declines ODDS (%) | 11 days ago 90% | 12 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PCEF | 19.37 | 0.21 | +1.10% |
| Invesco CEF Income Composite ETF (PCEF) | |||
| ESGV | 136.54 | 0.70 | +0.52% |
| Vanguard ESG U.S. Stock ETF (ESGV) | |||
| OCTT | 48.85 | 0.13 | +0.28% |
| AllianzIM U.S. Equity Buffer10 Oct ETF (OCTT) | |||
| XDEC | 44.02 | 0.05 | +0.10% |
| FT Vest U.S. Equity Enhance & Moderate Buffer ETF - December (XDEC) | |||
| CPXR | 31.11 | -0.32 | -1.02% |
| Uscf Daily Target 2X Copper Index ETF | |||